Japan Starts Special Approval Process for Remdesivir, NHK Says

Bookmark
(Bloomberg) -- Japan’s Health Ministry has begun a special approval process for the antiviral drug remdesivir as a potential treatment for Covid-19, NHK reported.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.